A new study announced by Istituto Superiore di Sanità (ISS, Rome, Italy) and published in "Frontiers in Immunology, February 13, 2019" suggests new avenues toward cure of HIV: the administration of the recombinant HIV-1 Tat protein (rTAT) to people...
TRICCAR Holdings, Inc., aka, TRICCAR, today announced an addition to its Board of Directors and Scientific Advisory Board. Steve Hayden joins TRICCAR's Board of Directors as an outside director. Mr.
Jintel Health, a technology innovator in advanced analytics and artificial intelligence, announced today that it will combine its Precision Intelligence solutions with Intermountain Healthcare's Precision Medicine Program's genomic and clinical data to...
Innovative open source software, originally developed for public health, is freely available to EHR and PHR systems to support clinical decision support for immunizations.
S-cubed is pleased to announce that after a rigorous evaluation process, the Qlik development team have been awarded Specialization Status in the Pharmaceutical and Biotech Industries.
Docxonomy and fme partner to bring Intelligent Document Classification Solutions to the Life Sciences Industry using Artificial Intelligence capabilities
iAssay® Inc., a privately held developer of the world's first open platform, point of care (POC) reader for remote medical diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S.
Euphrates Vascular has received 510(k) clearance for sale of its ICHOR Percutaneous Reperfusion System, which is a minimally-invasive platform designed to treat organized thrombus and embolic events in the peripheral vasculature.
Kaydence Pharma AS, a development stage pharmaceutical company, is pleased to report that it has successfully completed a pre-IND (Investigational New Drug) meeting with the US Food and Drug Administration (FDA).
Smarteeva announced today that it has formed an Advisory Board to assist in implementing the Company's current plans and identifying means to capitalize on future growth opportunities.
Following is analysis from Generis: "ECM is now dead," wrote Gartner analyst Michael Woodbridge at the beginning of last year, proclaiming the "birth of content services." Essentially, Woodbridge argued that centralized ECMs were no longer fit for...
OncoBeta® GmbH, a commercial stage Medical Device Company specialized in innovative epidermal radioisotope therapies for Non-Melanocytic Skin Cancers (NMSCs), is proud to announce that it is listed as one of the Top 20 MedTech Solution Providers in...
TRIGR Therapeutics, Inc. ("TRIGR"), a privately held biotechnology company focused on the clinical development and commercialization of bispecific antibody therapeutics for oncology and ophthalmology indications, announced that it will present at Biotech.
This article provides an overview of the current state of the use of TRIZ in the pharmaceutical industry and our R&D efforts in that area, based on TRIZ and computer mathematical modeling.
A new study announced by Istituto Superiore di Sanità (ISS, Rome, Italy) and published in "Frontiers in Immunology, February 13, 2019" suggests new avenues toward cure of HIV: the administration of the recombinant HIV-1 Tat protein (rTAT) to people...
OriGen Biomedical, Inc., a global medical device manufacturer focused on the production of cryopreservation, cell culture and ECMO respiratory products, is pleased to announce that the United States Food and Drug Administration (FDA) has cleared the...
Hanwell wireless solutions are revolutionizing the environment monitoring market within vital biotech and pharma sectors across the USA via the opening of a subsidiary company, Hanwell Inc. and office in Virginia Beach.
immunoSCAPE Pte Ltd ("immunoSCAPE" or the "Company"), a leader in immune profiling, today announced the establishment of its first US office in Cambridge, MA.
Syrris provides award-winning chemistry products to a range of research and development chemists and engineers, including Xeros Technology Group, a company specializing in novel and sustainable polymer solutions to advance the commercial laundry...
LGM Pharma, an innovation-driven active pharmaceutical ingredient (API) company, headquartered in Erlanger, Kentucky with offices in Florida, New Jersey and Israel recently announced the appointment of Hamilton J.
TRICCAR Holdings, Inc., aka, TRICCAR, today announced an addition to its Board of Directors and Scientific Advisory Board. Steve Hayden joins TRICCAR's Board of Directors as an outside director. Mr.
Jintel Health, a technology innovator in advanced analytics and artificial intelligence, announced today that it will combine its Precision Intelligence solutions with Intermountain Healthcare's Precision Medicine Program's genomic and clinical data to...
Cambridge Healthtech Institute is honored to highlight the accomplishments and insights of women in science and is thrilled to bring some of the greatest industry leaders to PEGS Boston in recognition of their many contributions.
Innovative open source software, originally developed for public health, is freely available to EHR and PHR systems to support clinical decision support for immunizations.
S-cubed is pleased to announce that after a rigorous evaluation process, the Qlik development team have been awarded Specialization Status in the Pharmaceutical and Biotech Industries.
Docxonomy and fme partner to bring Intelligent Document Classification Solutions to the Life Sciences Industry using Artificial Intelligence capabilities
Biotech Support Group reports on a patent application describing the simplicity and efficiency of their hemoglobin depletion technology for improving bilirubin measurements. The citation is: Krishna, Neel K., and Kenji Cunnion.
Biotech Support Group reports on a patent application describing the simplicity and efficiency of their hemoglobin depletion technology for human stored red blood cells. The citation is: Rosin-Arbesfeld, Rina, and Ronen SIMAN-TOV.
iAssay® Inc., a privately held developer of the world's first open platform, point of care (POC) reader for remote medical diagnostics, announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S.
Driven by a growing pipeline of drugs for the treatment of chronic disorders, the large volume wearable injectors market is anticipated to grow at an annualized rate of over 40%, predicts Roots Analysis
